Managed two clinical-stage portfolio programs: Annamycin (anthracycline) and WP1122 (metabolism/glycosylation inhibitor).• R&D Operations: Managed R&D program operations including CMC, non-clinical, and regulatory activities. Supported clinical pharmacology efforts.• Planning & Budgeting: Developed and maintained integrated plans and $20M budget for R&D activities, including scenario planning, gap identification, timelines and resource allocation. Implemented and adapted the plans based on executive decisions and program development status.• Drug Supply Chain: Managed drug supply projection and planning.• Cross-Functional Collaboration: Coordinated with internal teams (e.g. CMC, non-clinical, clinical, accounting) and external partners (CROs, CDMOs, vendors) to ensure timely execution of responsibilities, budget adherence, milestone tracking, and risk mitigation.• Regulatory Submission/Response: Led and facilitated the preparation of regulatory documents for US and global regulatory agencies, including DSUR, briefing documents for FDA Type D meeting, EMA Scientific Advice meeting, DSUR, IMPD. • Quality Support: Managed interactions with UK/EU Quality Person(QP) and supported the team in responding to QP queries. Assisted the Quality Director in developing SOPs for R&D activities.• Relationship Building: Fostered collaborative relationships with internal team members, external collaborators, CDMOs, CROs.• Operational Excellence: Conducted internal and external meetings, organized agendas, prepared meeting minutes, and followed up on action items. Utilized tools such as MS Project, Smartsheet, PowerPoint, and Excel to track, manage, and report project/program activities.• Communication: Effectively and timely communicated technical information and key activities to stakeholders and senior leadership through emails, verbal reports, and presentations. Provided visualizations summarizing project status, risks, required actions, and associated timelines.

Managed three therapeutic programs focusing on developing small molecule therapeutics for various indications including cancer, CNS disorders, asthma, and IPF. One program was at discovery stage, two programs were at development stage.• Strategy Development: Created short- and long-term program strategies to guide development and execution.• Budget & Timeline Management: Developed and managed project scope, timelines, and a $1 million budget for one program.• Leadership: Led internal and external teams in the design and execution of projects, ensuring adherence to timelines and budgets.• Third-Party Coordination: Worked closely and managed relationships with third-party CROs, consultants, and collaborators to support program goals.• Scientific Communication: Analyzed, interpreted, and communicated complex scientific topics to investors clearly and effectively.• Marketing Oversight: Supervised the marketing team in creating non-confidential content for the company’s website and social media profiles.• Spinout Support: Assisted spinout company Allterum with CMC activities for a biologic therapeutic, including reviewing cell line stability reports, cell line development reports, and analytical results for proving and demo run materials. Allterum is developing a novel biologic therapeutic for cancer treatment.• Team Supervision: Supervised a team of 8 interns, providing guidance and support in their roles.

• Program Management: Led two therapeutic programs, including developing research strategies, scouting and establishing relationships with CROs, coordinating in-house experiments, and evaluating experimental results.• Drug Discovery Leadership: Led a drug discovery project and R&D studies for a leading portfolio program.• Recruitment: Contributed as a member of the recruiting team for new fellows and interns.

• Due Diligence: Conducted thorough evaluations of potential academic technologies (e.g., MDACC, UH, UT, UMICH) for in-licensing, including technical validation, market analysis, competitive analysis, and assessment of potential indication expansion.• Project Leadership: Initiated and led three projects focused on developing in-house therapeutics for respiratory diseases, secured non-dilutive funding, and established collaborations with academic partners.• Marketing Support: Assisted the marketing team in creating non-confidential content for the company’s website and social media profiles. Prepared on-page materials for investor meetings.

• Studied the role of the tumor suppressor WISP3 in the development of metaplastic breast carcinoma.• Presented scientific discoveries at 1 national conference• Published 1 first-authored and 2 co-authored papers in top tiers peer-reviewed scientific journals

• Provided hands-on training in lab techniques and direct guidance on research methodology and project development.

Worked closely with the editor-in-chief, the executive manager, coordinators, and other editors to collect, evaluate, edit and publish manuscripts submitted.

Undergraduate courses taught: Protein Biotechnology, Biology, Introduction to Biotechnology.

Studied the mechanism of progression and metastasis of bladder cancer.